|
Market Closed -
Nasdaq
16:00:00 2026-01-05 EST
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| 04-15 | Evotec Taps CureVac Executive as COO | MT |
| 01-06 | CureVac ends coverage after BioNTech acquisition |  |
| Market Cap | 867M 994M 816M 744M 1.39B 95.25B 1.4B 9.78B 3.77B 48.52B 3.73B 3.65B 157B | P/E 2023 |
-3.23x | P/E 2024 | 4.57x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 486M 399M 364M 682M 46.6B 683M 4.78B 1.84B 23.74B 1.83B 1.79B 76.6B | EV / Sales 2023 |
9.16x | EV / Sales 2024 | 0.55x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: CureVac
| 1 day | -0.21% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 4 | | 5.55 |
| 3 years | 2.22 | | 7.66 |
| 5 years | 2.22 | | 58.36 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2023-03-27 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Malte Greune
COO | Chief Operating Officer | 61 | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 2015-07-31 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 2015-07-31 |
| Director/Board Member | 69 | 2022-06-21 |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 53.76M 61.66M 50.63M 46.11M 86.45M 5.91B 86.56M 606M 234M 3.01B 232M 226M 9.71B | 535M 614M 504M 459M 861M 58.8B 862M 6.04B 2.33B 29.96B 2.31B 2.25B 96.66B |
| Net income | -260M -298M -245M -223M -418M -28.59B -419M -2.93B -1.13B -14.56B -1.12B -1.1B -46.99B | 162M 186M 153M 139M 261M 17.82B 261M 1.83B 705M 9.08B 699M 683M 29.29B |
| Net Debt | -361M -414M -340M -309M -580M -39.63B -581M -4.07B -1.57B -20.19B -1.55B -1.52B -65.14B | -443M -508M -417M -380M -712M -48.65B -713M -4.99B -1.92B -24.78B -1.91B -1.87B -79.97B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions
